Skip to main content

Table 3 Oncological outcomes

From: Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial

Total cohort

 Variable

RLRN(n = 60)

TLRN(n = 60)

P value

 Recurrence, n (%)

12(20)

7(11.7)

0.211a

 Death, n (%)

5(8.3)

5(8.3)

1.000a

 Cancer related death, n (%)

4(6.7)

1(1.7)

0.361a

 Time of follow-up, mo, median (IQR)

34.6(21.3–51)

38.3(24.6–47)

0.503b

T1 subgroup

 Variable

RLRN(n = 38)

TLRN(n = 37)

P value

 Recurrence, n (%)

1(2.6)

2(5.4)

0.981a

 Death, n (%)

2(5.3)

2(5.4)

1.000a

 Cancer related death, n (%)

1(2.6)

0(0)

1.000a

T2 subgroup

 Variable

RLRN(n = 22)

TLRN(n = 23)

P value

 Recurrence, n (%)

11(50)

5(21.7)

0.048a

 Death, n (%)

3(13.6)

3(13)

1.000a

 Cancer related death, n (%)

3(13.6)

1(4.3)

0.568a

  1. aPearson’s χ2 test (or Fisher’s exact test)
  2. bMann-Whitney U test